AMMONIUM SULFATE CAS N°: 7783-20-2
AMMONIUM SULFATE CAS N°: 7783-20-2
AMMONIUM SULFATE CAS N°: 7783-20-2
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
OECD SIDS<br />
<strong>AMMONIUM</strong> <strong>SULFATE</strong><br />
5. TOXICITY ID: <strong>7783</strong>-<strong>20</strong>-2<br />
DATE: 18.04.<strong>20</strong>06<br />
Conclusion: Exposure to levels of 300 mg/m3 (mean diameter<br />
1-2 um) for up to 8 hours per day in 14 days did not<br />
result in any significant changes in lung morphology, lung<br />
volumes and arterial blood gases.<br />
Reliability: (4) not assignable<br />
limited documentation, no information on purity and particle<br />
size distribution (SD), only lung, trachea and bronchial<br />
lymphnodes examined, only one dose tested.<br />
The interval between termination of exposure and examination<br />
was too long.<br />
Flag:<br />
Critical study for SIDS endpoint<br />
25-AUG-<strong>20</strong>05 (1<strong>20</strong>)<br />
Type:<br />
Sub-acute<br />
Species: rat Sex: male<br />
Strain:<br />
Sprague-Dawley<br />
Route of administration: inhalation<br />
Exposure period:<br />
4 weeks<br />
Frequency of treatment: 6 hours/day, 5 days/week<br />
Post exposure period: no<br />
Doses:<br />
1.03 mg/m3 (MMAD 0.42 um)<br />
Control Group:<br />
other: sham exposed<br />
Remark:<br />
The study was designed to investigate effects of ammonium<br />
sulfate in normal animals and animals pretreated with<br />
elastase, which results in lung emphysema. Only the results<br />
for ammonium sulfate vs. air controls are reported in detail.<br />
Result: Pathological examination of rats exposed for <strong>20</strong> days to 1.03<br />
mg/m3 ammonium sulfate aerosol revealed a measurable degree of<br />
enlargement of alveoli, alveolar ducts and sacs. Alveolar pore<br />
size was not increased.<br />
The authors concluded that elastase pretreatment did not<br />
enhance or even obscure the effect of ammonium sulfate on<br />
alveolar structure at these exposure levels after short-term<br />
treatment.<br />
Test condition: Young adult specific pathogen free animals were maintained<br />
in isolation for 3 weeks prior to beginning experimental<br />
procedures. Animals were assigned to four experimental<br />
groups based on their initial weights, so that the<br />
distribution of animal weights for each treatment group was<br />
the same. The animals were divided into two groups, one to<br />
receive intratracheally instilled porcine pancreatic<br />
elastase ("elastase impaired") and one to receive saline<br />
solution intratracheally (controls). 40 rats received 75<br />
units of elastase activity / 100 g bw. The dose level was<br />
determined in preliminary experiments to produce a<br />
predictable degree of emphysema without inducing significant<br />
mortality. 40 rats received saline.<br />
Sterile elastase or saline solutions, standardized for<br />
activity (in the case of elastase), osmolarity, pH, and<br />
temperature, were administered intratracheally to<br />
ether-anesthetized animals. The total volume of the<br />
instillate varied slightly, depending on animal weight;<br />
however, concentration/volume was constant. Following<br />
recovery from anesthesia, the animals were caged for a<br />
3-week recovery period, during which (as in the initial<br />
isolation period) rats were maintained on tetracycline<br />
administered via drinking water. This procedure was found<br />
164<br />
UNEP PUBLICATIONS